Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels
Authors:
- Gabriela Nestal de MoraesGMGabriela Nestal de Moraes
- Flavia C. VasconcelosFVFlavia C. Vasconcelos
- Deborah DelbueDDDeborah Delbue
- Giuliana P. MognolGMGiuliana P. Mognol
- Cinthya SternbergCSCinthya Sternberg
- João P.B. ViolaJVJoão P.B. Viola
- Raquel C. MaiaRMRaquel C. Maia
- 1 August 2013
- journal article
- Published by Elsevier in European Journal of Cell Biology
- Vol. 92 (8-9) , 247-256
Abstract
No abstract availableKeywords
Funding Information
- Instituto Nacional de Ciência e Tecnologia
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo a Pesquisa do Rio de Janeiro
This publication has 49 references indexed in Scilit:
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Secondary mutations of BRCA1/2 and drug resistanceCancer Science, 2010
- Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast CancerJournal of Clinical Oncology, 2010
- Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to AdriamycinBiochemical Pharmacology, 2009
- Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory CancerJournal of Clinical Oncology, 2009
- Effect of hypoxia-inducible factor-1α on transcription of survivin in non-small cell lung cancerJournal of Experimental & Clinical Cancer Research, 2009
- Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancerCancer Treatment Reviews, 2008
- Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionMolecular Cancer Therapeutics, 2008
- TP53and breast cancerHuman Mutation, 2003
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997